A phased, low‑risk Operational Pilot Programme centred on health protection, evidence generation, and a procedurally proper MOD decision pathway. Designed for initial circulation to the Operational Energy Authority / Defence Fuels Technical Authority, Defence safety leadership / assurance functions, the Surgeon General function, and the Military Aviation Authority.
This package seeks permission to evaluate DoC Jet A-1 in a controlled manner — not immediate fleet‑wide adoption.
This submission is framed as a forward‑looking engineering, health‑protection, and decision‑support proposal. It does not ask the Ministry of Defence to make any retrospective admission of fault. It asks only that the MOD evaluate an available, specification‑compliant fuel option that may materially reduce naphthalene‑derived soot exposure in rotary‑wing operations.
DM‑XTech proposes a phased Operational Pilot Programme beginning with a controlled Engine Test Bay evaluation during scheduled maintenance and progressing, only if the data support it, to a single‑airbase operational trial monitored independently by the Translational Energy Research Centre (TERC), University of Sheffield. This keeps the initial approval narrow, reversible, and procedurally disciplined.
For first‑wave issue, circulate this package to the Operational Energy Authority / Defence Fuels Technical Authority, the Defence safety / health‑protection function, the Surgeon General function, and the MAA. Parliamentary, media, claimant‑facing, and quantified legal‑risk materials should remain reserved unless specifically requested or unless MOD engagement clearly stalls.
DM‑XTech requests: (1) nomination of a lead technical point of contact; (2) a joint technical meeting with OEA / DFTA, Defence safety, and relevant stakeholders; (3) agreement in principle to scope a Phase Zero Engine Test Bay evaluation during scheduled maintenance; and (4) review of the proposed independent monitoring framework and data package.
TERC ICP‑OES trace‑element screening records, ASTM D1655 / DEF STAN 91‑091 certification, and emissions characterisation form the core of the technical dossier. The attached TERC appendix now substantiates the specific ICP‑OES screening references for DoC Jet A-1 and Jet A‑1 baseline, while dedicated seal‑compatibility substantiation is reserved for the separate zLCAF pathway. This is the neutral, citation‑heavy evidence base suitable for MOD technical panels, the Chief Scientific Adviser, and independent scientific review.
Publicly reported claims activity, compensation history, and the defensive value of a documented, good‑faith Pilot Programme are presented separately for MOD Legal and Treasury Solicitor audiences, without attributing past fault. The focus is on reducing future exposure and demonstrating responsible response to emerging evidence.
The phased Pilot Programme, no‑fault health protection framing, and Defence safety‑led evaluation pathway constitute the policy transition instrument — a way for MOD leadership to act decisively, protect personnel, and improve its decision record without any requirement for retrospective admission of liability.
This integrated version preserves the no‑fault, institutionally safe tone of the revised submission while incorporating four operational refinements from the earlier strategy build: (1) explicit acknowledgement that the current TERC evidence is highly persuasive but still benefits from a representative turboshaft Engine Test Bay confirmation; (2) early, formal engagement with the Military Aviation Authority (MAA); (3) a distinct supply‑chain and counterparty‑assurance package for DE&S scrutiny; and (4) a sequenced engagement model in which parliamentary and adversarial channels are held in reserve until the MOD has first had a proper opportunity to respond to the technical submission.
A specification‑compliant fuel retaining the ≥8% aromatics position DM‑XTech relies on for ASTM D7566 / DEF STAN 91‑091 context, while sharply reducing soot and naphthalene exposure.
DoC Jet A-1 is not a speculative biofuel or an experimental blend. It is a precision‑engineered aviation fuel that meets every parameter of ASTM D1655 and DEF STAN 91‑091. For DoC Jet A-1, the materials / legacy‑use position advanced in this pack is that the fuel retains at least 8% total aromatics, consistent with the ASTM D7566 / DEF STAN 91‑091 aromatic‑content basis cited by DM‑XTech, rather than a separate standalone seal‑compatibility claim. Its distinguishing feature is the deliberate reduction of naphthalene content to <100 ppm, compared with the 30,000 ppm maximum (and 8,000–20,000 ppm typical) permitted in standard Jet A‑1, and the resulting reduction in soot and polycyclic aromatic hydrocarbon (PAH) emissions under partial‑power rotary‑wing operating conditions.
ASTM D1655 and DEF STAN 91‑091 certification establish that DoC Jet A-1 is a fully specification‑compliant, drop‑in aviation turbine fuel. They do not eliminate the need for proper MOD institutional process. Any base‑level fuel supply change will still engage MAA airworthiness scrutiny and local engineering governance. That is why the proposed sequence leads with the Engine Test Bay phase: it generates representative MOD‑supervised data at minimal cost and near‑zero operational risk, thereby converting a theoretical regulatory question into an evidence‑backed approval pathway.
| Parameter | Standard Jet A‑1 | DoC Jet A-1 | Delta | Operational / Legal Relevance |
|---|---|---|---|---|
| Soot particles (idle / hover) | Baseline (100%) | Up to 20% of baseline | −80% | Direct reduction in PAH‑laden ultrafine particles in crew breathing zone during hover and hot loading. |
| Naphthalene content | Up to 30,000 ppm (8,000–20,000 typical) | <100 ppm | −99.7% vs spec max | Substantially reduces one fuel‑borne aromatic species that is central to current public scrutiny of rotary‑wing exhaust exposure. |
| Unburned hydrocarbons (idle) | Baseline (100%) | 66.7% of baseline | −33.3% | Reduced ground‑level fume exposure for aircrew and ground crew during prolonged idling. |
| Total aromatics | Up to 25% vol (specification limit framework) | 8.5% vol total aromatics | Meets DM‑XTech minimum | Supports the ≥8% aromatics position DM‑XTech relies on for ASTM D7566 / DEF STAN 91‑091 context while keeping naphthalene very low. |
| Soot particles (full power) | Baseline (100%) | 50–60% of baseline | −40 to −50% | Contrail formation reduction; climate benefit under EU 2024/2493. |
| Legacy materials / seal position | Established service history on standard Jet A‑1 | Not separately bench‑claimed here; DoC Jet A-1 instead relies on meeting the ≥8% aromatics position. | Framed conservatively | Dedicated seal‑compatibility substantiation belongs to zLCAF and is planned first at TERC, then through ASTM D4054 if initial testing is successful. |
| Internal engine soot deposition | Baseline (100%) | Proportional to 80% soot reduction | Significantly reduced | Lower hot‑section fouling; extended maintenance intervals; reduced injector coking; improved fleet availability. |
| Fuel density at 15°C | 775–840 kg/m³ | 791.4 kg/m³ | Optimal | Mid‑range — no range, performance or weight adjustments required. |
| ASTM D1655 (civil Jet A‑1 spec) | Meets | Meets | CERTIFIED | Specification compliance supports consideration as a drop‑in fuel, subject to MOD QA, airworthiness, and local engineering governance for the proposed evaluation. |
| DEF STAN 91‑091 (UK military spec) | Meets | Meets | CERTIFIED | Creates a credible basis for MOD procurement review, but routing, contractual treatment and QA acceptance should be confirmed with OEA / DFTA and the relevant commercial authority. |
A funded, monitored, scientifically rigorous programme designed to generate definitive operational data and a stronger MOD decision record, beginning in a controlled ground environment before any flight testing.
DM‑XTech’s strategic ask to the MOD is deliberately modest and tactically constructed to remove every conceivable institutional objection. Rather than requesting full fleet adoption, which would trigger the standard Defence procurement process timelines measured in years, DM‑XTech proposes a phased, risk‑minimised Operational Pilot Programme beginning with controlled engine test bay validation before progressing to live flight operations at a single airbase.
The programme begins where risk is lowest and evidence is strongest: in an Engine Test Bay. Before any fuel enters an operational aircraft in flight, DoC Jet A-1 will be run through a full‑power engine test cycle under controlled ground conditions, ideally integrated into a scheduled Major Inspection, where the engine is already stripped, inspected, and run on a test stand as a matter of routine. This creates a tightly bounded entry point. The engine is already being tested. The test bay is already instrumented. The fuel is the only variable. The MOD can evaluate DoC Jet A-1’s combustion behaviour, soot output, and engine response data in the safest possible environment, inside a controlled facility with full telemetry, before committing to a single flight hour.
DM‑XTech acknowledges that airflow dynamics around a helicopter in flight differ from those in an engine test bay: the rotor downwash recirculation loop, the cabin air intake geometry, and the variable power demands of a live sortie cannot be fully replicated on a ground stand. That is precisely why the Engine Test Bay phase is positioned as a precursor, not a substitute, for in‑flight validation. Its purpose is threefold: to demonstrate that DoC Jet A-1’s combustion performance matches the TERC laboratory data in an operationally representative military engine; to generate the initial confidence required for flight authorisation; and to neutralise the objection, which sceptics will certainly raise, that the MOD is being asked to put an unfamiliar fuel into flying aircraft without prior ground‑based validation in its own facilities.
The Pilot Programme is framed not as open‑ended fuel research but as a controlled health‑protection and decision‑support exercise. Its phased structure, test bay first and airbase evaluation only if justified, allows MOD to gather evidence without committing in advance to fleet conversion. That procedural conservatism is central to the proposal’s credibility.
For the avoidance of doubt, DM‑XTech does not invite the Ministry to make any retrospective admission of liability or fault. The proposed Pilot Programme is framed explicitly as a forward‑looking, no‑fault health protection and evidence‑gathering exercise, consistent with the MOD’s existing statutory duties and internal governance. All language, documentation and public communications can be structured accordingly.
Treat the Pilot Programme as a controlled decision‑support exercise, not as a request for immediate fleet conversion. The value proposition is that MOD can generate its own ground‑based and then operational evidence on a specification‑compliant lower‑soot, lower‑naphthalene fuel option before deciding whether any wider adoption step is justified.
The initial ask is deliberately narrow. It begins with a single Engine Test Bay run during scheduled maintenance, under MOD supervision, with independent monitoring. If that bounded ground phase is satisfactory, the next step is a single‑airbase evaluation under agreed QA, engineering, and governance controls. Each stage is designed to answer a specific institutional question with MOD‑owned evidence.
That sequencing is what makes the proposal compelling: it is procedurally conservative, operationally contained, and capable of being stopped at any stage if the evidence does not support progression.
In any large organisation, and particularly within defence procurement, there will be individuals whose instinct is to delay, to question, to defer to established practice. Some will argue — despite the TERC validation data, despite the ASTM and DEF STAN certification — that an unfamiliar fuel should not be placed into operational aircraft without extensive further testing. The Engine Test Bay Precursor Phase is designed specifically to answer that objection.
DM‑XTech does not ask the MOD to accept its word. It does not ask the MOD to trust laboratory data alone. It asks the MOD to run DoC Jet A-1 through its own engine, in its own test facility, under its own supervision, during maintenance that is already scheduled and budgeted. The sceptic’s question, "How do we know this fuel is suitable for our platforms and our processes?", is answered by the MOD’s own data, generated in the MOD’s own facilities, before any aircraft leaves the ground. The incremental cost of answering that question should be comparatively modest relative to a full operational trial, but it should still be validated with the host maintenance organisation and MOD sponsor before commitment.
Phase Zero is the lowest‑risk, lowest‑cost entry point available: a controlled Engine Test Bay evaluation of DoC Jet A-1 conducted during a scheduled Major Inspection of a representative military turboshaft engine. During any Major Inspection, the engine is already removed from the airframe, stripped, inspected, reassembled, and subjected to a full‑power test bay run as standard procedure. DM‑XTech proposes that the test bay run at the conclusion of one such scheduled inspection be conducted using DoC Jet A-1 instead of standard Jet A‑1, with TERC instrumentation measuring soot output, exhaust gas composition, and engine performance parameters in real time.
This phase is comparatively low cost because the engine run, facility and maintenance activity are already scheduled. The principal incremental items are the trial fuel, agreed monitoring / instrumentation, and any academic oversight the parties decide to add. Final cost would need to be validated with the host maintenance organisation and MOD sponsor, but the phase remains materially smaller and lower‑risk than any direct operational trial. If the results are satisfactory, the MOD then has its first independent, in‑house, operationally representative data point on which to decide whether any later flight trial is justified.
Critically, no aircraft flies during Phase Zero. The engine runs in a controlled ground facility. Any sceptic who argues that DoC Jet A-1 is an unknown quantity is answered by the fact that the MOD’s own engine test infrastructure has validated it, on a military engine, at military power settings, under MOD supervision — before a single flight hour is committed.
Operational risk: bounded and comparatively low for the proposed ground phase. The engine would be ground‑mounted in a test bay and operated by qualified personnel within an existing maintenance framework. Because DoC Jet A-1 is presented as ASTM D1655 / DEF STAN 91‑091 compliant, the main remaining issues are not basic fuel‑specification questions but MOD process, QA acceptance, configuration control, and any local authorisations the host organisation requires. No aircraft flight activity is proposed in this phase. Final go / no‑go should therefore be taken only after OEA / DFTA, the host engineering authority, and any relevant airworthiness stakeholders confirm the exact pathway.
Phase One commences upon successful completion of the Engine Test Bay Precursor Phase, using the TERC Precursor Phase Report as the evidential basis for progression. With ground‑based engine validation data in hand, Phase One establishes the formal commercial and legal framework for the airbase flight trial. The engagement plan is sequenced rather than indiscriminately simultaneous: OEA / DFTA and Defence safety functions are engaged first, followed by the Surgeon General and MAA regulatory route, with parliamentary and adversarial channels reserved for use only if the MOD fails to engage within a reasonable window. The strategic objective is to create momentum without triggering avoidable institutional defensiveness.
The primary deliverable of Phase One is a signed Heads of Terms or Letter of Intent between DM‑XTech and the MOD confirming the Pilot Programme scope, airbase selection, commercial terms, monitoring framework, and funding arrangement. A secondary deliverable is the formal instruction of TERC as independent data monitor for the programme.
Phase Two establishes the operational baseline against which DoC Jet A-1’s performance will be measured and delivers the first DoC Jet A-1 supply to the target airbase. This phase is critically important from a scientific and legal standpoint: the rigour with which baseline measurements are taken will determine the evidentiary strength of the Pilot Programme data.
Baseline measurement is conducted over a four‑week period using the target airbase’s existing fuel, standard Jet A‑1, while deploying all monitoring equipment. This creates a controlled within‑site comparison using the same aircraft, the same engines, the same crew, the same airbase geometry, and the same operational tempo. The only variable changed in Phase Three is the fuel.
Phase Three is the core operational period: six months of DoC Jet A-1 use across the target airbase’s helicopter fleet, with continuous real‑time monitoring and structured data collection. The monitoring framework is designed to generate data robust enough to serve simultaneously as scientific evidence, legal evidence, and operational validation.
Throughout Phase Three, TERC maintains independent oversight of all data collection, ensuring that neither DM‑XTech nor the MOD can be accused of selectively presenting results. All raw monitoring data is stored in a secured TERC research database with chain‑of‑custody documentation suitable for evidential use in legal proceedings.
Phase Four consolidates the Pilot Programme data into a comprehensive operational evidence package, presents the findings to MOD leadership, and develops the formal recommendation for full fleet adoption. This phase is structured to remove every institutional objection to adoption: technical (the data is robust), legal (the evidence record is chain‑of‑custody certified), logistical (the supply chain is proven), and operational (no performance degradation is observed).
The Phase Four report is structured to serve triple purposes: as a scientific publication (in partnership with TERC and the University of Sheffield), as a procurement justification document for the DE&S full fleet adoption decision, and as a legal record demonstrating the MOD’s active response to identified occupational health risks — improving its litigation defence position materially and immediately.
| Airbase | Primary Platform(s) | Selection Rationale | Priority |
|---|---|---|---|
| RAF Benson, Oxfordshire | Puma HC2; H135 Juno; H145 Jupiter (HQ Air Wing) | Highest concentration of legacy rotorcraft in UK RAF order of battle; proximity to DE&S (Bristol) and MOD Main Building; mixed‑platform fleet maximises data richness. | Highest Priority |
| RNAS Yeovilton, Somerset | Wildcat HMA2; Merlin HM2; Merlin HC4 | RN helicopter concentration; Merlin HC4 uses legacy Rolls‑Royce RTM322 and remains a high‑value operationally relevant platform; proximity to Westland/Leonardo Helicopters supports OEM dialogue if required. | Highest Priority |
| RAF Valley, Anglesey | H135 Juno; H145 Jupiter (Defence Helicopter Flying School) | High training sortie rate = high fuel volume throughput for data volume; concentrated aircrew population enables robust biomonitoring study. | High Priority |
| RAF Shawbury, Shropshire | H135 Juno; Bell Griffin HT1 (Defence Helicopter Flying School) | Training rotary‑wing base; publicly reported exhaust‑exposure concern; high sortie tempo; strong candidate for controlled monitoring. | High Priority |
| AAC Middle Wallop, Hampshire | Wildcat AH1; Apache AH‑64E | Army Air Corps base; AH1 operational platform; broader Army interest in DoC Jet A-1 if Navy/RAF adoption proceeds. | Secondary |
| Cost Element | Estimated Cost (GBP) | Who Bears Cost | Rationale |
|---|---|---|---|
| DoC Jet A-1 Fuel Supply (6 months, est. 1,000–2,000 t) | GBP 780,000 – 1,560,000 | MOD (at DoC Jet A-1 price vs. Jet A‑1 differential) | Net incremental cost after Jet A‑1 base price; Jet A‑1 cost displaced. |
| TERC Monitoring Infrastructure & Personnel | GBP 350,000 – 500,000 | MOD (Pilot Programme funding) | Independent academic monitoring required for legal evidentiary value. |
| Crew Biomonitoring Programme | GBP 80,000 – 120,000 | MOD / DM‑XTech (shared) | Urinary metabolite analysis across 40–80 volunteer participants. |
| Fuel System Inspection & Engineering Assurance | GBP 50,000 – 80,000 | MOD (existing maintenance schedule) | Marginal cost above routine 500‑hour fuel system inspection. |
| DM‑XTech Programme Management | GBP 150,000 – 200,000 | DM‑XTech | Commercial and technical programme management at no cost to MOD. |
| Total Estimated MOD Contribution | GBP 1.26M – 2.26M | MOD | Indicative only — final scope and cost to be agreed with MOD sponsor |
| Planning note | Costs shown are provisional planning numbers for DM‑XTech internal use. A narrower Engine Test Bay phase would be materially smaller and should be scoped separately before any full pilot commitment. | ||
Initial circulation should remain technical, occupational‑health, and regulatory in tone. Parliamentary, media, and adversarial materials should remain in reserve unless MOD engagement stalls.
The vectors are sequenced, not launched simultaneously. The first objective is a serious technical hearing inside the MOD. External escalation should be reserved for later use, after the Ministry has had a reasonable opportunity to review and respond to the substantive engineering case.
The MOD should first encounter DoC Jet A-1 as a technical, health‑protection, and regulatory matter. The sequencing below preserves that discipline by leading with the OEA / DFTA and Defence Safety submission, bringing in the Surgeon General and MAA early, and holding wider external channels in reserve. Recipient titles and internal mailboxes should be verified immediately before dispatch.
For actual submission use, this section is best treated as an internal working note rather than part of the first‑wave recipient package. Its function is to preserve orderly follow‑up, evidence logging, and escalation discipline.
The vectors are sequenced, not all launched on Day 1. If the MOD first discovers the proposal through Parliament, media, or hostile legal correspondence, the offer is more likely to be characterised as a political pressure tactic rather than a serious engineering solution. The formal submission should therefore land first. External escalation is retained as leverage, but used only after the MOD has had a reasonable opportunity to respond.
Concurrent submission to the Operational Energy Authority / Defence Fuels Technical Authority (OEA / DFTA) and the Defence safety / health‑protection function activates both fuel‑governance and occupational‑risk pathways at the outset. This remains the principal channel and the one through which the Engine Test Bay ask should be framed.
A medical and occupational‑health brief should follow as a distinct clinical referral, focused on exposure reduction, biomonitoring logic, and the case for a formal Defence health risk assessment.
Early MAA engagement strengthens credibility by explicitly acknowledging that a base fuel supply change, though specification‑compliant, still sits inside the military airworthiness framework. The ask is for guidance, not confrontation.
Parliamentary briefing remains valuable, but should ordinarily be deployed only if the MOD fails to provide a substantive response after the technical submission has been received and followed up.
The legal vector is strongest when it shows that DM‑XTech first attempted good‑faith technical engagement. That sequencing materially improves the evidential force of any later notice to claimants’ advisers.
Week 1: OEA / DFTA + Defence Safety. Week 2: Surgeon General + MAA request. Week 4–6: formal follow‑ups and technical clarification. Week 6–8 only if required: parliamentary and external legal briefing.
DM‑XTech is not asking the MOD to admit fault. It is offering a low‑risk way to improve present and future risk posture. MOD‑facing documents should therefore remain collaborative, technically dense, and procedurally respectful. The harder liability language belongs only in the legal channel, and only if escalation becomes necessary.
| Audience | Primary frame | Key message | Deployment |
|---|---|---|---|
| Operational Energy Authority / Defence Fuels Technical Authority (OEA / DFTA) | Controlled pilot procurement | ASTM / DEF STAN certified drop‑in fuel; Engine Test Bay first; standard QA chain; defined commercial package. | Week 1 |
| Director Defence Safety / Defence Safety Authority | Statutory health protection | Evidence of an available exposure‑control measure now warrants evaluation and documented decision‑making. | Week 1 |
| MOD Surgeon General | Clinical referral | Exposure reduction, biomonitoring design, and whether a Defence health risk assessment should be commissioned. | Week 2 |
| Military Aviation Authority | Regulatory guidance | Confirm evidence expectations and approval path for a compliant fuel supply change supported by Engine Test Bay data. | Week 2 |
| Defence Committee | Parliamentary accountability | A bounded, specification‑compliant evaluation pathway has been offered and the MOD has been given a reasonable opportunity to respond. | Conditional, Week 6–8 |
| Claimants’ solicitors | Preservation of evidential leverage | DM‑XTech pursued a collaborative route first; any later notice is therefore harder for the MOD to dismiss as tactical. | Conditional, Week 6–8 |
Procurement credibility requires a clear answer not only on the fuel, but on who makes it, how quality is assured, and how the MOD is protected if supply is interrupted.
One of the most useful additions from the earlier file is the explicit recognition that DE&S will assess supply resilience and counterparty stability separately from fuel chemistry. This section is therefore included directly in the core document rather than left implicit.
| Stage | Primary function | Why it matters to MOD |
|---|---|---|
| Feedstock sourcing | Hydrotreated base stock plus monocyclic aromatics from commercially available petrochemical inputs. | Avoids dependence on exotic or scarce specialty molecules. |
| TERC Pilot Plant | Precision blending, batch control, and pilot‑programme production at Sheffield. | Provides controlled initial supply for Engine Test Bay and pilot volumes. |
| ASTM / DEF STAN QA | Full specification testing and certificate of quality for each batch before shipment. | Ensures no batch is supplied outside standard aviation fuel acceptance logic. |
| Logistics and tankerage | Standard aviation fuel transport chain with chain‑of‑custody documentation. | Minimises infrastructure novelty and uses familiar handling practice. |
| MOD acceptance on receipt | Normal incoming QA inspection under existing fuel acceptance discipline. | Confirms there is no request for any procedural shortcut or exemption. |
The earlier strategy correctly anticipated DE&S commercial diligence. The hybrid document therefore recommends that Heads of Terms expressly address: escrow or step‑in rights for the formulation package if commercially appropriate, visibility of relevant licence security terms under NDA, standard batch‑level QA and chain‑of‑custody documents, and an explicit statement that any supply interruption during the pilot simply triggers immediate reversion to conventional Jet A‑1 with no operational impact.
Internal planning note to support disciplined follow‑up, evidence logging, and proportionate escalation.
Plan internally for a 12–18 month pathway to Engine Test Bay execution, with six months treated as an optimistic case. This timetable is a management tool for DM‑XTech, not a timetable that must appear in the first‑wave MOD submission package.
| Scenario | Meaning | Recommended response |
|---|---|---|
| Immediate technical engagement | The preferred outcome: the MOD accepts a serious engineering conversation. | Prioritise Engine Test Bay scheduling and keep all external channels on hold. |
| Further review requested | Normal and manageable, provided the review has named owners and dates. | Support review promptly; keep evidence log current; maintain MAA and Surgeon General tracks. |
| Routing into slow procurement only | Risk that the health and liability dimensions are being diluted into routine process. | Escalate within the MOD first and re‑emphasise the health‑protection framing. |
| Non‑response | The evidential value of the chronology begins to increase. | Deploy parliamentary and legal channels in documented sequence. |
Initial submission set for MOD circulation, with reserved annexes retained below for contingency planning.
Each recipient‑facing document should stand on its own. The OEA / DFTA + Defence Safety submission should read as a controlled evaluation proposal; the Surgeon General brief as an occupational‑health note; the MAA paper as a pathway consultation; and any parliamentary, media, or legal documents as reserved contingency materials.
For actual MOD circulation, keep the first wave collaborative, evidence‑led, and non‑accusatory. Sharper liability framing and external‑pressure materials should be retained only as reserve documents or produced later if requested.
For a first‑wave MOD send, use: (1) Formal Technical Submission; (2) Surgeon General Occupational Health Brief; (3) MAA Regulatory Pathway Note; (4) Operational Pilot Programme Proposal; plus Annex A. Keep the parliamentary, media, claimant‑facing, and legal‑risk papers as reserved annexes.
Lead document for first‑wave MOD circulation to the current public fuel and Defence safety functions.
Dear Sir / Madam,
DM‑XTech UK Ltd hereby submits for consideration a formal technical proposal for the controlled evaluation, on a funded pilot basis, of its Duty-of-Care Jet A-1 (DoC Jet A-1) at a designated UK military airbase operating a high concentration of rotary‑wing aircraft.
This submission is framed for simultaneous routing to the MOD fuel authority and the Defence safety / health‑protection function because the proposal engages fuel QA and supply, occupational‑health risk management, and airworthiness pathway definition. It is copied to the MOD Surgeon General and the MOD Chief Scientific Adviser because the initial decision sought is a controlled evaluation, not an immediate fleet conversion.
Publicly available material — including the IMEG seventh report, the 8 July 2025 Westminster Hall debate on military helicopters and blood cancers, and earlier MOD‑related exhaust‑exposure reporting — shows that rotary‑wing exhaust exposure remains a serious subject of occupational‑health and parliamentary concern. Those same public sources also indicate that the currently available evidence does not establish causation to the threshold applied by IMEG. DM‑XTech therefore does not ask the MOD to accept any causal conclusion. It asks only that MOD examine whether a specification‑compliant lower‑naphthalene, lower‑soot fuel merits controlled evaluation as a prudent exposure‑reduction option.
Recent public litigation, published research, and wider operational concern indicate that this issue warrants documented technical evaluation. DM‑XTech makes no comment on the legal merits of any individual claim and raises that background only to explain why a forward‑looking exposure‑reduction trial is now timely.
DM‑XTech UK Ltd has developed and independently validated a precision‑engineered aviation fuel, DoC Jet A-1, that directly addresses the fuel‑composition variable DM‑XTech proposes should be evaluated under MOD supervision:
Full TERC validation data, certification documentation, and technical specifications are enclosed with this submission as Appendix A.
DM‑XTech proposes that the Ministry of Defence authorise a phased Operational Pilot Programme designed to minimise risk at every stage. The programme begins not with flight testing but with a controlled Engine Test Bay evaluation, conducted during a scheduled Major Inspection of a representative military turboshaft engine, before progressing to a six‑month airbase flight trial.
The Engine Test Bay phase is designed to carry low incremental operational risk: the engine would be ground‑mounted in a test facility and operated within an existing maintenance framework, with no aircraft flight activity proposed in this phase. The principal additional items are the trial fuel, agreed monitoring instrumentation, and any independent oversight. Final cost and authorisation route should be validated with the host maintenance organisation, OEA / DFTA, and any relevant airworthiness stakeholders before execution. This precursor phase is intended to generate MOD‑owned, independently monitored, operationally representative performance data before any commitment to a flight trial is considered.
Subject to satisfactory Engine Test Bay results, DM‑XTech proposes that the Ministry subsequently authorise a six‑month Operational Pilot Programme at a single designated military airbase with a high concentration of rotary‑wing aircraft. DM‑XTech does not request full fleet adoption at this stage; it requests the opportunity to demonstrate DoC Jet A-1’s performance under real‑world operational conditions, with independent academic monitoring, and to generate the evidence base required for an informed full fleet adoption decision.
The Pilot Programme is designed to achieve four outcomes simultaneously: (a) generate operational‑scale performance data capable of confirming or challenging the TERC laboratory results; (b) test whether DoC Jet A-1 produces a measurable improvement in the exposure environment for aircrew and ground personnel at the designated airbase; (c) establish a formal institutional record of the MOD’s active, good‑faith response to a reported occupational‑health concern; and (d) if the evidence supports it, inform any later commercial and implementation discussion on a proper evidential footing.
DM‑XTech’s current internal planning estimate for the six‑month Pilot Programme is set out in the accompanying programme proposal, but that figure remains provisional pending MOD scoping. The immediate decision sought is narrower still: agreement to scope the Engine Test Bay Precursor Phase and the associated technical review meeting.
For the avoidance of doubt, DM‑XTech does not invite the Ministry to make any retrospective admission of liability or fault. The proposed Pilot Programme is framed explicitly as a forward‑looking, no‑fault health protection and evidence‑gathering exercise, consistent with the MOD’s existing statutory duties and internal governance.
DM‑XTech respectfully requests: (a) written acknowledgement of this submission within ten working days; (b) a formal technical briefing meeting within thirty working days; and (c) identification of a scheduled Major Inspection of a representative turboshaft engine at which the Engine Test Bay Precursor Phase can be conducted, ideally within sixty working days of this submission.
DM‑XTech emphasises that the Engine Test Bay Precursor Phase requires no flight authorisation, no operational disruption, and minimal incremental cost. It is the lowest‑risk first step available and provides the MOD with its own data, generated in its own facilities, under its own supervision, from which to make any subsequent decision with full confidence.
DM‑XTech is prepared to make its scientific and technical data available, under appropriate non‑disclosure arrangements, to any MOD technical panel, scientific adviser, or independent reviewer the Ministry wishes to appoint.
This submission is made in good faith and in the shared interest of protecting the health of UK armed forces personnel. DM‑XTech looks forward to the Ministry’s response and to the opportunity to present its evidence in detail.
Deo C. Reloj, Jr.
Chief Executive Officer
DM-XTech UK Ltd
Enclosures: Appendix A (TERC Validation Report & Certification); Appendix B (Pilot Programme Proposal: Full Detail); Appendix C (DoC Jet A-1 Technical Specification Sheet)
Supporting occupational‑health brief for initial circulation.
Dear Surgeon General,
This brief sets out the occupational health relevance of DoC Jet A-1, a DEF STAN 91‑091‑certified aviation fuel formulated to reduce naphthalene‑derived soot emissions from legacy rotary‑wing engines, and proposes a monitored Pilot Programme as a proportionate health protection measure under your existing mandate.
Existing litigation and research indicate that aircrew and ground personnel operating around legacy military helicopters are exposed to PAH‑laden ultrafine particles generated from naphthalene‑containing Jet A‑1 under partial‑power conditions. Biomonitoring studies in comparable civilian cohorts demonstrate elevated urinary PAH metabolites in exposed workers.
DoC Jet A-1 reduces naphthalene content to <100 ppm and has demonstrated up to 80% soot mass reduction at idle in a representative gas turbine. It is fully compliant with DEF STAN 91‑091 and is proposed for controlled evaluation without any planned aircraft, engine or ground‑infrastructure modification at pilot stage. DM‑XTech submits that it merits evaluation as a potential engineering / substitution‑type control measure within a COSHH‑style exposure‑control framework.
DM‑XTech respectfully invites your office to consider commissioning a Defence Health Risk Assessment on naphthalene and PAH exposure in rotary‑wing operations, with DoC Jet A-1 evaluated as a candidate control measure, and to support the proposed Pilot Programme as a health protection trial rather than a procurement initiative.
Deo C. Reloj, Jr.
Chief Executive Officer — DM-XTech UK Ltd
Supporting regulatory pathway note for initial circulation.
Dear Airworthiness Team,
DM‑XTech writes to seek early guidance on the appropriate regulatory pathway for a proposed, tightly controlled evaluation of Duty-of-Care Jet A-1 (DoC Jet A-1), a DEF STAN 91‑091 and ASTM D1655 compliant aviation turbine fuel formulated to reduce naphthalene and soot precursors while retaining the ≥8% aromatics basis DM‑XTech relies on for legacy‑fleet context.
We do not suggest that specification compliance alone removes the need for military regulatory process. Rather, our position is that the proposed Engine Test Bay precursor phase is specifically designed to generate the representative evidence that MAA and associated engineering authorities may wish to see before any controlled single‑airbase operational trial is considered.
The objective of this note is not to press for immediate operational authorisation. It is to ensure that the evidence‑generation plan is aligned from the outset with MAA expectations, including any requirements arising in practice under the RA 1000 series framework and any base‑level modification or fuel supply change governance.
DM‑XTech would be grateful for non‑binding early guidance on the following points:
DM‑XTech’s aim is to follow the correct institutional route, to minimise operational risk, and to ensure that any future submission is framed in a way that is technically useful to MAA review rather than procedurally premature. We would therefore welcome the opportunity for a short exploratory discussion at your convenience.
DM-XTech UK Ltd
Prepared for structured, non‑adversarial regulatory engagement.
Reserved contingency note. Not recommended for first‑wave MOD circulation.
This briefing note is submitted to members of the House of Commons Defence Committee who have engaged with concerns raised about reported exhaust‑exposure issues affecting UK military helicopter crews. Its purpose is to bring to the Committee’s attention that a specification‑compliant lower‑naphthalene, lower‑soot aviation fuel option is now available, has been independently tested, and has been formally offered to the Ministry of Defence for controlled evaluation.
Standard Jet A‑1 aviation fuel can contain naphthalene at concentrations permitted up to 30,000 parts per million maximum (typical 8,000–20,000 ppm). DM‑XTech’s case is that lower naphthalene content should translate into lower soot loading under the operating conditions that matter most in legacy rotary‑wing use. Public reporting has also described a January 2024 settlement involving the estate of Flight Sergeant Zach Stubbings and wider claims activity by current and former aircrew. DM‑XTech does not ask the Committee to take a view on legal merits; it asks only that the existence of a controlled, specification‑compliant evaluation pathway be noted.
DM‑XTech UK Ltd has developed an aviation fuel, DoC Jet A-1, that contains less than 100 parts per million of naphthalene, compared to the 30,000 ppm maximum (8,000–20,000 ppm typical) permitted in standard Jet A‑1. Independent testing at TERC demonstrated an 80% reduction in soot mass and a 99.7% reduction in naphthalene content (versus specification maximum) relative to standard Jet A‑1. DoC Jet A-1 is presented as DEF STAN 91‑091 compliant and is intended to be evaluated without planned hardware modification; MOD process and QA acceptance still need to be confirmed.
DM‑XTech has formally submitted a proposal to the Ministry of Defence for a phased, controlled evaluation beginning with an Engine Test Bay step and potentially progressing to a single‑airbase pilot if the evidence supports it. Provisional programme cost planning is set out in the internal pack, but the immediate request is narrower: a technical meeting and scoped ground phase. The formal submission is routed to the MOD fuel authority and Defence safety function, with copies to the Surgeon General function and the MAA consultation route.
DM‑XTech does not seek to predetermine any procurement decision and makes no comment on the legal merits of any individual claim. It respectfully invites members of the Committee to note: (a) that an independently validated, specification‑compliant lower‑soot fuel option now exists; (b) that it has been formally offered to the Ministry of Defence for controlled evaluation; and (c) that the way MOD responds to an available exposure‑reduction option is a legitimate subject of parliamentary interest.
DM‑XTech’s technical team and TERC researchers are available to brief the Committee, or its staff, at any time. Full validation data and certification documentation will be provided on request.
Deo C. Reloj, Jr.
Chief Executive Officer — DM-XTech UK Ltd
www.dmxtech.co.uk
Reserved external‑facing note for possible later use outside the initial MOD submission process.
Dear [Partner / Solicitor],
DM‑XTechnologies Inc. (DM-XTechPhil) is the developer of Duty-of-Care (DoC Jet A-1), an aviation fuel formulated to materially reduce naphthalene content and soot emissions from legacy military helicopter engines. I write to bring to your attention evidence that may be relevant to the reported exhaust‑exposure proceedings you are conducting on behalf of former UK military helicopter aircrew and their estates.
I write not as an adversary of the Ministry of Defence, but as a commercial entity that has developed a validated lower‑soot, lower‑naphthalene fuel option and that has, as of the date of this letter, formally submitted that option to the MOD with a proposal for a controlled evaluation programme. The relevance of this evidence to your proceedings arises not from our role but from the scientific and procedural implications of the evidence itself.
Public reporting around the Zach Stubbings settlement and wider claims activity has focused attention on whether legacy rotary‑wing exhaust exposure could have materially contributed to later disease. DM‑XTech does not offer a legal conclusion on causation. Its point is narrower: if fuel composition materially changes soot formation, then the existence of a specification‑compliant lower‑soot alternative may become relevant to questions of mitigation, knowledge, and post‑notification conduct.
DM‑XTech’s evidence bears on two aspects of this chain that may strengthen future proceedings:
DM‑XTech is prepared to provide your expert witnesses with: the full TERC validation dataset and methodology; the ASTM D1655 and DEF STAN 91‑091 certification documentation for DoC Jet A-1; a technical briefing from TERC researchers on the combustion chemistry of naphthalene pyrolysis and the measured difference between Jet A‑1 and DoC Jet A-1 soot output; and, if required and appropriate, expert witness availability from DM‑XTech’s technical team.
DM‑XTech makes no warranty as to the outcome of any legal proceedings and this letter does not constitute legal advice. DM‑XTech’s interest is in seeing DoC Jet A-1 adopted by the MOD; facilitating the legal record reflects our honest assessment that the scientific evidence justifies serious consideration of controlled MOD evaluation.
I would welcome a confidential call or meeting at your earliest convenience.
Deo C. Reloj, Jr.
Chief Executive Officer
DM-XTech UK Ltd
www.dmxtech.co.uk
Core technical and commercial annex supporting the initial submission set.
Operation CLEAR BURN is a phased, funded, independently monitored Operational Pilot Programme beginning with a controlled Engine Test Bay evaluation and progressing to a live airbase flight trial. Its purpose is to evaluate the operational performance, health protection outcomes, and fuel system compatibility of DoC Jet A-1 as a drop‑in replacement for standard Jet A‑1 in legacy rotary‑wing operations.
Prior to any airbase deployment, a controlled Engine Test Bay evaluation will be conducted during a scheduled Major Inspection of a representative military turboshaft engine at an MOD‑approved Depth Maintenance facility. The engine test bay run will follow standard Major Inspection test profiles using DoC Jet A-1 in place of standard Jet A‑1, with TERC exhaust characterisation instrumentation deployed at the test bay stack. This phase is designed to avoid flight activity in this phase and should carry comparatively low incremental cost relative to a full operational trial; final authorisation route and cost should be validated with the host maintenance organisation and MOD sponsor.
Air Quality Monitoring: Continuous ambient particulate monitoring (PM₁, PM₂.₅, PM₁₀) at apron, crew room, and refuelling stations. Weekly averaged data submitted to TERC. Naphthalene and total VOC concentrations measured by photo‑ionisation detection.
Exhaust Characterisation: Monthly DMS500 aerosol spectrometer measurements during representative operational sorties, hover, transit, and hot‑loading flight phases, for each aircraft type present at the station.
Crew Biomonitoring: Urinary analysis of volunteer participants for naphthalene and PAH exposure markers, pre‑ and post‑duty‑cycle monthly.
Fume Event Log: Structured standardised self‑report database for any cabin air quality complaint, odour event, neurological symptom, or eye/respiratory irritation.
Fuel System Integrity: Scheduled inspection of fuel system seals on all participating aircraft at 500‑hour intervals.
Engine Condition & Maintenance Impact: Borescope imagery and EHM trend data compared before and during DoC Jet A-1 operation to quantify engine cleanliness improvements and inform maintenance interval extension recommendations.
DM‑XTech proposes the following commercial structure for MOD consideration:
Operation CLEAR BURN is better characterised as a controlled evaluation of an alternative fuel within a health‑protection and engineering‑assurance context, rather than as an immediate fleet‑replacement competition. The exact governance route should be settled with OEA / DFTA, Defence Safety, the host maintenance organisation, and any relevant airworthiness stakeholders.
The phased structure provides a lower‑commitment route into the evidence base: Phase Zero (Engine Test Bay) is designed as the narrowest and lowest‑risk entry step. The exact authorisation path should be settled case‑by‑case with the host maintenance organisation, OEA / DFTA, and any relevant airworthiness stakeholders. Any decision to progress to an airbase flight trial should then be made on the basis of the MOD’s own evidence, not DM‑XTech’s claims.
DM-XTech UK Ltd
Programme Reference: DMX-PPP-001
Contact: www.dmxtech.co.uk
Reserved supporting note for use only if MOD legal or finance teams request quantified risk context.
Public reporting in 2025 referred to around 180 current and former aircrew pursuing claims linked to helicopter exhaust exposure, alongside a previously reported January 2024 settlement involving the estate of Zach Stubbings. DM‑XTech includes that context here only as a marker of live external scrutiny, not as a quantified statement of MOD liability.
This note intentionally avoids asserting aggregate liability numbers. The more defensible point is procedural: where claims activity and parliamentary scrutiny already exist, a documented good‑faith evaluation of an available exposure‑reduction option may improve litigation posture more credibly than inaction.
A documented evaluation of DoC Jet A-1 may provide the MOD legal team with three procedural advantages:
The estimated net incremental cost to the MOD of the six‑month Pilot Programme remains a provisional planning figure pending MOD scoping. The more prudent point is not any single ratio; it is that a documented good‑faith evaluation of an available control measure may materially improve MOD’s future decision record while also generating operational evidence.
DM‑XTech further notes that the proposed programme begins with an Engine Test Bay Precursor Phase whose incremental cost should be materially smaller than a full operational pilot, although the number should still be validated with the host maintenance organisation and MOD sponsor. Even if the MOD’s legal advisers are not yet prepared to support the full Pilot Programme commitment, the ground phase alone may still be the most proportionate way to improve the decision record.
DM-XTech UK Ltd
For further analysis: www.dmxtech.co.uk
Reserved media background material. Excluded from first‑wave MOD circulation.
The story in brief: Following years of public concern and claims activity around UK military helicopter exhaust exposure, a British fuel technology company has developed and independently tested an aviation fuel that materially lowers naphthalene content and soot output while being presented as specification‑compliant. The fuel has been formally offered to the Ministry of Defence for controlled evaluation. The MOD has not yet agreed to run a trial.
Standard jet fuel contains a chemical called naphthalene, in concentrations of up to 30,000 parts per million maximum (3% by volume, typically 8,000–20,000 ppm). When naphthalene burns in a helicopter engine at low power, during hovering, patrolling or training, it does not fully combust. Instead, it breaks down into a cascade of toxic soot particles containing PAHs. Some of these compounds are subject to established toxicological concern.
Helicopter engines, unlike jet aircraft engines, are frequently run at partial power. Helicopter rotor blades push exhaust air back toward the aircraft. The result is that crew breathe recycled, soot‑laden exhaust throughout a sortie. DM‑XTech’s fuel, DoC Jet A-1, contains less than 100 parts per million of naphthalene. In independent university testing, it reduced soot emissions from the same engine by up to 80%. It is certified to every applicable UK military fuel standard. It is proposed for controlled evaluation without any planned aircraft modification at pilot stage.
Media enquiries: DM-XTech UK Ltd — www.dmxtech.co.uk
Certification, standards and supporting technical reference for all submissions.
| Standard / Parameter | Specification | DoC Jet A-1 Result | Status |
|---|---|---|---|
| ASTM D1655 | US/Civil Jet A‑1 specification covering flash point, freezing point, density, viscosity, thermal stability, and materials compatibility. | Full compliance across all test parameters. | CERTIFIED |
| DEF STAN 91‑091 | UK MOD aviation turbine fuel specification — includes all ASTM D1655 requirements plus additional MOD‑specific parameters. | Full compliance across all test parameters. | CERTIFIED |
| Total aromatics (ASTM D1319 / ASTM D7566 context) | ASTM D1655 maximum 25% vol; DM‑XTech relies on a minimum 8% aromatics position for ASTM D7566 / DEF STAN 91‑091 legacy‑fleet context. | 8.5% vol total aromatics. | PASS |
| Naphthalene content (ASTM D1840) | Maximum 3.0% vol (30,000 ppm) under ASTM D1655 and DEF STAN 91‑091 (typical values 8,000–20,000 ppm). | <100 ppm (0.00100% vol) — 352× below the maximum permitted. | PASS (far below limit) |
| Density at 15°C (ASTM D4052) | 775–840 kg/m³ | 791.4 kg/m³ — mid‑range optimum. | PASS |
| Flash point (ASTM D56) | Minimum 38°C | Meets specification. | PASS |
| Freezing point (ASTM D2386) | Maximum −47°C | Meets specification. | PASS |
| Thermal stability (JFTOT, ASTM D3241) | 260°C minimum; tube deposit rating ≤3; pressure drop <25 mmHg. | Meets specification. | PASS |
| TERC ICP‑OES trace‑element screening — calcium | SAFL‑035 / ASTM D7111‑16‑based in‑house method; not a primary ASTM D1655 pass/fail parameter. | 0.037 mg/kg for DoC Jet A-1 vs 0.004 mg/kg Jet A‑1 baseline. | RECORDED |
| TERC ICP‑OES trace‑element screening — lead | SAFL‑035 / ASTM D7111‑16‑based in‑house method; not a primary ASTM D1655 pass/fail parameter. | 0.011 mg/kg for DoC Jet A-1 vs 0.064 mg/kg Jet A‑1 baseline. | RECORDED |
| Seal / materials compatibility claim boundary | DoC Jet A-1 pack relies on aromatics content and specification compliance; separate zero‑aromatics materials substantiation is a distinct issue. | No standalone DoC Jet A-1 seal‑compatibility confirmation is asserted here. Dedicated seal‑compatibility work relates to zLCAF, planned first at TERC and then, if successful, through ASTM D4054. | DELIMITED |
| Document / Standard | Relevance |
|---|---|
| Secretary of State for Defence — Health, Safety and Environment in Defence Policy Statement (2 January 2024) | Publicly confirms that the Second Permanent Secretary is the Department’s most senior official for HSE matters, that DG DSA provides independent assurance, and that Director Defence Safety supports health and safety functional leadership from Head Office. |
| JSP 317 Part 1 (current public issue checked March 2026) | Publicly identifies the Operational Energy Authority (OEA) as commodity manager for MOD fuels and gases and the Defence Fuels Technical Authority (DFTA) as the nominated technical authority for fuel QA policy, advice, and fitness‑for‑use recommendations. |
| RA 1910 Issue 6 (updated 30 September 2024) | Relevant public MAA regulation on quality assurance of aviation fuel from non‑UK MOD sources. Useful as a public QA pathway reference; does not remove the need for MOD‑specific routing and local engineering governance. |
| DEF STAN 91‑091 | UK military aviation turbine fuel specification. Compliance supports technical eligibility for consideration, but does not by itself bypass MOD process, QA acceptance, contractual routing, or any required airworthiness review. |
| IMEG Seventh Report (public report, Topic 6) | Important public evidence boundary: IMEG reported that the available evidence did not meet its threshold to establish a causal link between Sea King helicopter exhaust fumes or benzene and the cancers discussed there. This supports framing the proposal as a precautionary evaluation, not as an assertion that causation is already established. |
| Hansard — Westminster Hall debate, 8 July 2025, “Military Helicopters: Blood Cancers” | Shows that the issue remains under active parliamentary scrutiny and that the public debate is current, even while causation remains contested. |
| House of Commons Defence Committee (current committee name) | Correct public committee name for any reserved parliamentary annex. “Defence Committee” is the current formal name; “Defence Select Committee” is not preferred in current public usage. |
| IARC Monograph 82 — Naphthalene | Provides toxicological context for naphthalene as an IARC Group 2B possible human carcinogen. Useful as background context, but not a substitute for MOD‑specific exposure and causation evidence. |
The attached DM‑XTech appendix now provides direct copies of the TERC / SAF‑IC ICP‑OES trace‑element reports for LCAF Jet A1 (Test Ref SAFL‑035) and Jet A1 Baseline (Test Ref SAFL‑034), both dated 23 January 2025 and performed using an in‑house jet‑fuel method based on ASTM D7111‑16 (2021). This Pass 4 has therefore been rewritten to distinguish clearly between: (1) the DoC Jet A-1 evidence now directly supported by those appended TERC records; and (2) the separate seal‑compatibility / zero‑aromatics pathway for zLCAF, which is planned for initial TERC testing and, if successful, subsequent progression into the ASTM D4054 approvals process.
Institutional titles and pathway references in this Pass 4 were checked against publicly available MOD and Parliament sources current as of March 2026, including the Secretary of State for Defence’s HSE in Defence Policy Statement, the current public issue of JSP 317 Part 1, RA 1910 Issue 6, the IMEG seventh report, the 8 July 2025 Westminster Hall debate on military helicopters and blood cancers, and the House of Commons Defence Committee pages. Internal routing, named mailboxes, commercial treatment and any Defence‑internal process steps should still be confirmed by directory check or sponsor contact before dispatch.